MA45141A - PROCESS FOR THE PREPARATION OF N- (5- (3- (7- (3-FLUOROPHENYL)) - 3 H-IMIDAZO [4,5-C] PYRIDIN-2-YL) -1H-INDAZOL-5-YL) PYRIDIN- 3-YL) -3-METHYLBUTANAMIDE - Google Patents

PROCESS FOR THE PREPARATION OF N- (5- (3- (7- (3-FLUOROPHENYL)) - 3 H-IMIDAZO [4,5-C] PYRIDIN-2-YL) -1H-INDAZOL-5-YL) PYRIDIN- 3-YL) -3-METHYLBUTANAMIDE

Info

Publication number
MA45141A
MA45141A MA045141A MA45141A MA45141A MA 45141 A MA45141 A MA 45141A MA 045141 A MA045141 A MA 045141A MA 45141 A MA45141 A MA 45141A MA 45141 A MA45141 A MA 45141A
Authority
MA
Morocco
Prior art keywords
pyridin
methylbutanamide
indazol
imidazo
fluorophenyl
Prior art date
Application number
MA045141A
Other languages
French (fr)
Other versions
MA45141B1 (en
Inventor
Sunil Kumar Kc
Original Assignee
Samumed Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samumed Llc filed Critical Samumed Llc
Priority claimed from PCT/US2017/035411 external-priority patent/WO2017210407A1/en
Publication of MA45141A publication Critical patent/MA45141A/en
Publication of MA45141B1 publication Critical patent/MA45141B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA45141A 2016-06-01 2017-06-01 Process for the preparation of n-(5-(3-(7-(3-fluorophenyl))-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin- 3-yl)-3-methylbutanamide MA45141B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662344170P 2016-06-01 2016-06-01
PCT/US2017/035411 WO2017210407A1 (en) 2016-06-01 2017-06-01 Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

Publications (2)

Publication Number Publication Date
MA45141A true MA45141A (en) 2019-04-10
MA45141B1 MA45141B1 (en) 2022-12-30

Family

ID=84783663

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45141A MA45141B1 (en) 2016-06-01 2017-06-01 Process for the preparation of n-(5-(3-(7-(3-fluorophenyl))-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin- 3-yl)-3-methylbutanamide

Country Status (1)

Country Link
MA (1) MA45141B1 (en)

Also Published As

Publication number Publication date
MA45141B1 (en) 2022-12-30

Similar Documents

Publication Publication Date Title
IL263362B (en) Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
IL286912A (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
SI3555097T1 (en) Imidazo(4,5-d)pyrrolo(2,3-b)pyridine compounds as inhibitors of janus kinases
IL270134B (en) Process for preparing optically active 2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium compounds
PT3805233T (en) (r) and (s) enantiomer of n-(5-(3-hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-carboxamide as irak4 inhibitors for treating cancer and inflammatory diseases
LT3500571T (en) IMIDAZO[1,2-a]PYRIDIN COMPOUNDS, COMPOSITIONS COMPRISING THEM, METHODS FOR TREATING DISEASES USING THEM, AND METHODS FOR PREPARING THEM
FR22C1058I2 (en) TABLET FORMULATION OF 2-FLUORO-N-METHYL-4-[7-(QUINOLINE -6-YLMETHYL) IMIDAZO[1,2-B][1,2,4]TRIAZINE -2-YL]BENZAMIDE
IL269214B (en) Novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors
EP3362205A4 (en) Methods for improving the thermal treatment of castings
IL276483B1 (en) Continuous process for the preparation of trazodone
IL269215A (en) Cyclic substituted imidazo[4,5-c]quinoline derivatives
PL3228619T3 (en) Process for the preparation of apixaban
MA45141A (en) PROCESS FOR THE PREPARATION OF N- (5- (3- (7- (3-FLUOROPHENYL)) - 3 H-IMIDAZO [4,5-C] PYRIDIN-2-YL) -1H-INDAZOL-5-YL) PYRIDIN- 3-YL) -3-METHYLBUTANAMIDE
PL3478684T3 (en) New processes for the preparation of vemurafenib
PL3277687T3 (en) 7-(morpholin-4-yl)pyrazole[1,5-a]pyrimidine derivatives which are useful for the treatment of immune or inflammatory diseases or cancer
IL265985A (en) Process for the preparation of (3s,4s)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3h-imidazo[4,5-c]pyridine-5(4h)-carboxylate
MA52183A (en) PROCESS FOR THE PREPARATION OF 2,2-DIMETHYLPIPERAZINE